Innovative Egg Assessment Tool From Canadian Med-Tech Startup Future Fertility Has Been Adopted For Patient Use by Trio Fertility

August 11, 2020

TORONTO, Aug. 11, 2020 /PRNewswire/ – Canadian startup company Future Fertility has commercially launched a product that is providing a new solution in the field of Assisted Reproductive Technology (ART). Their newly marketed product Violet™ is a cloud-based software that assesses the probability of an oocyte (human egg) to successfully fertilize and reach a blastocyst embryo stage. Violet™, an AI-based image technology that has been optimized through scientific collaborations with several In-Vitro Fertilization (IVF) clinics around the world, analyzes 2-D images of a patient’s eggs in real-time. Until now, there has been no accepted method to visually grade an egg or predict its reproductive potential.

> Continue reading

Related posts

February 14, 2019

IVF coverage by employers on the rise? How to know what your company offers?

Infertility coverage is the in-demand benefit of the moment for women and more companies are stepping up to offer to [...]
January 08, 2021

Women May Soon Start Using AI to Tell Good Eggs From Bad

Future Fertility, the first company to use artificial intelligence to grade the viability of women’s harvested eggs for use in [...]
January 08, 2021

Diana Olusanmi is one of MaRS 21 Canadian tech entrepreneurs to watch in 2021

Diana Olusanmi moves the needle on fertility options Despite all the developments made in reproductive science since the first “test [...]